Latest News and Press Releases
Want to stay updated on the latest news?
-
VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) (“Hydreight” or the “Company”), a leading provider of compliant...
-
Austin, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Light Therapy Market Size & Growth Analysis: According to industry estimates, the Light Therapy Market was valued at USD 1.17 Billion in 2025...
-
VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) (“Anfield” or the “Company”) is pleased to announce that it has signed a...
-
TORONTO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Talisker Resources Ltd. (“Talisker” or the “Company”) (TSX: TSK, OTCQX: TSKFF) announces that further to the Company’s news release of December 17, 2025,...
-
The combination of denifanstat and resmetirom was generally well-toleratedPharmacokinetic (PK) results support further development of the combinationA Phase 2 trial of a denifanstat/resmetirom...
-
Largest Exchange Transfer in History & Biggest IPO of the Year Highest Capital Raised Since 2021 - $46.65 Billion Raised NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ)...
-
- Data expected in Q2 2026 - DUBLIN, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives,...
-
Results showed CNS target engagement with reduction in GCase substrate glucosylsphingosine (GluSph) in cerebrospinal fluid (CSF), a prespecified endpoint The reduction in GluSph in CSF, a first-ever...
-
Toronto, Ontario, Dec. 18, 2025 (GLOBE NEWSWIRE) -- King’s Hawaiian, known for its irresistibly soft, fluffy, and signature sweet rolls, is bringing a taste of paradise to Toronto this holiday...
-
Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference